Skip to main content
SpringerLink
Log in

Liver Cancer: Stem and Progenitor Cells

  • Reference work entry
  • First Online:
Tumors and Tumor-Like Lesions of the Hepatobiliary Tract

Abstract

Stem cells are involved in hepatocarcinogenic pathways. In the normal liver, hepatic stem cells are self-renewing cells dwelling in distinct compartments termed stem cell niches. These niches are distinct microenvironments which maintain the balance of slow self-renewal of quiescent stem cells and their priming to become hepatocytes and other differentiated cells. Hepatic stem cells possess plasticity, allowing them to undergo lineage diversification. In hepatocarcinogenesis, tumor stem cells mimick certain features of their normal counterparts. Tumor stem cells in hepatocellular carcinoma (HCC) can act as tumor-initiating cells and tumor-propagating cells that express hepatic stem cell markers and show distinct gene expression profiles. Apart from their role in carcinogenic pathways, cancer stem cells in HCC are considered to play an important role in tumor recurrence and metastasis. The expression of stemness-related markers in HCC confers an aggressive phenotype in these neoplasms. Tumor stem cells in HCC modulate several processes, including maintenance of slowly cycling clonogenic cells having longevity, induction of distinct growth features, and tumor progression. Following removal of HCC and other liver cancers, tumor stem cells can remain in the liver and enter the bloodstream to settle in new stem cell niches, including metastatic niches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,599.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 2,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akita M, Tanaka K, Matsumoto S, Komatsu K, Fujita K (2013a) Detection of the hematopoietic stem and progenitor cell marker CD133 during angiogenesis in three-dimensional collagen gel culture. Stem Cells Int 2013:10

    Article  CAS  Google Scholar 

  • Akita M, Tanaka K, Murai N, Matsumoto S, Fujita K, Takaki T, Nishiyama H (2013b) Detection of CD133(prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5). Microsc Res Tech 76:844–852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW (2011) Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol 85:12292–12303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aliotta JM, Lee D, Puente N, Faradyan S, Sears EH, Amaral A, Goldberg L, Dooner MS et al (2012) Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells 21:1627–1638

    Article  CAS  Google Scholar 

  • Alisi A, Baffet G (2012) Self-renewal of tumor-initiating cells: what’s new about hepatocellular carcinoma ? Gastroenterology 142:1414–1416

    Article  PubMed  Google Scholar 

  • Alison MR, Poulsom R, Forbes SJ (2001) Update on hepatic stem cells. Liver 21:367–373

    Article  CAS  PubMed  Google Scholar 

  • Alison MR, Lovell MJ (2005) Liver cancer: the role of stem cells. Cell Prolif 38:407–421

    Article  CAS  PubMed  Google Scholar 

  • Alison MR, Islam S, Lim S (2009) Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 217:282–298

    Article  CAS  PubMed  Google Scholar 

  • Anderson LH, Boulanger CA, Smith GH, Carmeliet P, Watson CJ (2011) Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn 240:674–681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anthony DF, Shiels PG (2013) Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs. Transplant Res 2(1):10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barajas M, Franchi F, Clavel C, Aranguren XL, Kramer MG, Abizanda G, Merino J et al (2007) Multipotent adult progenitor cells (MAPC) contribute to hepatocarcinoma neovasculature. Biochem Biophys Res Commun 364:92–99

    Article  CAS  PubMed  Google Scholar 

  • Bauer N, Wilsch-Bräuninger M, Karbanova J, Fonseca AV, Strauss D, Freund D, Thiele C et al (2011) Haematopoietic stem cell differentiation promotes the release of prominin-1/containing membrane vesicles-a role of the endocytic-exocytic pathway. EMBO Mol Med 3:398–409

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Becker G, Schmitt-Graeff A, Ertelt V, Blum HE, Allgaier HP (2007) CD177 (c-kit) expression in human hepatocellular carcinoma. Clin Oncol (R Coll Radiol) 19:204–208

    Article  CAS  Google Scholar 

  • Behnke MK, Reimers M, Fisher RA (2013) Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications. Ann Hepatol 13:45–53

    PubMed  Google Scholar 

  • Bird TG, Lorenzini S, Forbes SJ (2008) Activation of stem cells in hepatic diseases. Cell Tissue Res 331:283–300

    Article  CAS  PubMed  Google Scholar 

  • Blechacz B, Mishra L (2013) Hepatocellular carcinoma biology. Recent Results Cancer Res 190:1–20

    Article  PubMed  Google Scholar 

  • Bogaerts E, Heindryckx F, Vandewynckel YP, Van Grunsven LA, Van Vlierberghe H (2014) The roles of transforming growth factor-b, Wnt. Notch and hypoxia on liver progenitor cells in primary liver tumours (review). Int J Oncol 44:1015–1022

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bolukbasi MF, Mizrak A, Ozdener GB, Madlener S, Ströbel T, Erkan EP, Fan JB et al (2012) miR-1289 and “zipcode”-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 1:e10

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bourseau-Guilmain E, Griveau A, Benoit JP, Garcion E (2011) The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One 6, e25515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bruno S, Collino F, Deregibus MC, Grange C, Tetta C, Camussi G (2013) Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev 22:758–771

    Article  CAS  PubMed  Google Scholar 

  • Calado RT, Dumitriu B (2013) Telomere dynamics in mice and humans. Semin Hematol 50:165–174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838–848

    Article  CAS  PubMed  Google Scholar 

  • Camussi G, Deregibus MC, Cantaluppi V (2013) Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 41:283–287

    Article  CAS  PubMed  Google Scholar 

  • Casal C, Torres-Collado AX, Plaza-Calonge MC, Martino-Echarri E, Ramon Y, Cajal S et al (2010) ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells. Cancer Res 70:4676–4686

    Article  CAS  PubMed  Google Scholar 

  • Chai S, Ma S (2013) Clinical implications of miRNAs in liver cancer stem cells. Chin J Cancer 32:419–426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chai S, Tong M, Ng KY, Kwan PS, Chan YP, Fung TM, Lee TK, Wong N, Xie D, Yuan YF, Guan XY et al (2014) Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. Oncotarget 5:5725–5735

    Article  PubMed  PubMed Central  Google Scholar 

  • Chan AW, Tong JH, Chan SL, Lai PB, To KF (2014) Expression of stemness markers (CD133 ad EpCAM) in prognostication of hepatocellular carcinoma. Histopathology 64:935–950

    Article  PubMed  Google Scholar 

  • Che N, Zhao XL, Sun T, Zhao XM, Gu Q, Dong XY, Zhao N, Liu YR, Yao Z, Sun BC (2011) The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study. Hum Pathol 42:840–847

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao W, Shao RG (2012) CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol Sci 8:992–1004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen YL, Yuan RH, Yang WC, Hsu HC, Jeng YM (2013a) The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing. J Pathol 229:486–496

    Article  CAS  PubMed  Google Scholar 

  • Chen K, Huang W, Huang B, Wie Y, Li B, Ge Y, Qin Y (2013b) BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma. Genet Test Mol Biomarkers 17:160–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Q, Khoury M, Limmon G, Choolani M, Chan JK, Chen J (2013c) Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells. Stem Cells 31:1160–1169

    Article  CAS  PubMed  Google Scholar 

  • Chen H, Luo Z, Dong L, Tan Y, Yang J, Feng G, Wu M, Li Z, Wang H (2013d) Cd133+/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival. PLoS One 8, e56878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Y, Verfaillie CM (2014) MicroRNAs: the fine modulators of liver development and function. Liver Int 34(7):976–990. doi:10.1111/liv.12496

    Article  CAS  PubMed  Google Scholar 

  • Cheng SW, Tsai HW, Lin YJ, Cheng PN, Chang YC, Yen CJ, Huang HP, Chuang YP et al (2013) Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma. PLoS One 8, e80053

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Cheung PF, Cheng CK, Wong NC, Ho JC, Yip CW, Liu VC, Cheung AN, Fan ST et al (2011) Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PLoS One 6, e28246

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiang CH, Huo TI, Sun CC, Hsieh JH, Chien Y, Lu KH, Lee SD (2013) Induced pluripotent stem cells and hepatic differentiation. J Chin Med Assoc 76:599–605

    Article  CAS  PubMed  Google Scholar 

  • Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44:240–251

    Article  CAS  PubMed  Google Scholar 

  • Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y, Yonemitsu Y, Yokosuka O et al (2008) The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 8:7742–7749

    Article  CAS  Google Scholar 

  • Chiba T, Kamiya A, Yokosuka O, Iwama A (2009) Cancer stem cells in hepatocellular carcinoma: recent progress and perspective. Cancer Lett 286:145–153

    Article  CAS  PubMed  Google Scholar 

  • Chow AK, Ng L, Lam CS, Wong SK, Wan TM, Cheng NS, Yau TC, Poon RT, Pang RW (2013) The enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance. PLoS One 8, e78675

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cicchini C, Amicone L, Alonzi T, Marchetti A, Mancone C, Tripodi M (2014) Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte. Liver Int 35(2):302–310. doi:10.1111/liv.12577

    Article  PubMed  PubMed Central  Google Scholar 

  • Colombo F, Baldan F, Mazzucchelli S, Martin-Padura I, Marighetti P, Cattaneo A, Foglieni B et al (2011) Evidence of distinct tumour-promoting cell populations with different properties in primary human hepatocellular carcinoma. PLoS One 6, e21369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crosby HA, Hubscher SG, Joplin RE, Kelly DA, Strain AJ (1998) Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 28:980–985

    Article  CAS  PubMed  Google Scholar 

  • Dabeva MD, Shafritz DA (2003) Hepatic stem cells and liver repopulation. Semin Liver Dis 23:349–362

    Article  CAS  PubMed  Google Scholar 

  • Dan YY, Yeoh GC (2008) Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 23:687–698

    Article  PubMed  Google Scholar 

  • Dang HT, Budhu A, Wang XW (2014) The origin of cancer stem cells. J Hepatol 60(6):1304–1305. doi:10.1016/j.hep.2014.03.001

    Article  PubMed  Google Scholar 

  • Darwiche H, Petersen BE (2010) Biology of the adult hepatic progenitor cell: “ghosts in the machine”. Prog Mol Biol Transl Sci 97:229–249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davoodian N, Lotfi AS, Soleimani M, Mola J (2014) MicroRNA-122 overexpression promotes hepatic differentiation of human adipose tissue-derived stem cells. J Cell Biochem 115(9):1582–1593. doi:10.1002/jcb.24822

    Article  CAS  PubMed  Google Scholar 

  • Deregibus MC, Cantalupi V, Calogero R, Lo IM, Tetta C, Biancone L, Bruno S et al (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440–2448

    Article  CAS  PubMed  Google Scholar 

  • Deregibus MC, Tetta C, Camussi G (2010) The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. Histol Histopathol 25:397–404

    CAS  PubMed  Google Scholar 

  • Dezso K, Halasz J, Bisgaard HC, Paku S, Turanyi E, Schaff Z, Nagy P (2008) Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastoma. Virchows Arch 452:443–448

    Article  CAS  PubMed  Google Scholar 

  • Ding YP, Yang XD, Wu Y, Xing CG (2014) Autophagy promotes the survival and development of tumors by participating in the formation of vasculogenic mimicry. Oncol Rep 31:2321–2327

    CAS  PubMed  Google Scholar 

  • Dong HH, Xiang S, Liang HF, Li CH, Zhang ZW, Chen XP (2013) The niche of hepatic cancer stem cell and cancer recurrence. Med Hypotheses 80:666–668

    Article  CAS  PubMed  Google Scholar 

  • Fan YZ, Sun W (2010) Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy. World J Gastrointest Surg 2:117–127

    Article  PubMed  PubMed Central  Google Scholar 

  • Fan L, He F, Liu H, Zhu J, Liu Y, Yin Z, Wang L, Guo Y, Wang Z, Yan Q, Huang G (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11:320

    Article  PubMed  PubMed Central  Google Scholar 

  • Fan YL, Zheng M, Tang YL, Liang XH (2013) A new perspective of vasculogenic mimicry: EMT and cancer stem cells (review). Oncol Lett 6(5):1174–1180

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, Wei LX (2014) Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 352:160–168

    Article  CAS  PubMed  Google Scholar 

  • Fargeas CA, Karbanova J, Jaszai J, Corbeil D (2011) CD133 and membrane microdomains: old facets for future hypotheses. World J Gastroenterol 17:4149–4152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117–130

    Article  CAS  PubMed  Google Scholar 

  • Folberg R, Hendrix MJ, Maniotis J (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361–381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Folberg R, Maniotis AJ (2004) Vasculogenic mimicry. APMIS 112:508–525

    Article  PubMed  Google Scholar 

  • Folini M, Gandellini P, Zaffaroni N (2009) Targeting the telosome: therapeutic implications. Biochim Biophys Acta 1792:309–316

    Article  CAS  PubMed  Google Scholar 

  • Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, Bruno S et al (2012) Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30:1985–1998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Forbes S, Vig P, Poulsom R, Thomas H, Alison M (2002) Hepatic stem cells. J Pathol 197:510–518

    Article  PubMed  Google Scholar 

  • French SW, Vitocruz E, French BA (2013) Balloon liver cells forming Mallory-Denk-bodies are progenitor cells. Exp Mol Pathol 95:117–120

    Article  CAS  PubMed  Google Scholar 

  • Frenkel S, Barzel I, Levy J, Lin AY, Bartsch DU, Majumdar D, Folberg R, Pe’er J (2008) Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond) 22:948–952

    Article  CAS  Google Scholar 

  • Fujii T, Zen Y, Harada K, Niwa H, Masuda S, Kaizaki Y, Watanabe K, Kawashima A et al (2008) Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma-human and cell culture study. Hum Pathol 39:1185–1196

    Article  CAS  PubMed  Google Scholar 

  • Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E et al (2011) Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm 8:1538–1548

    Article  CAS  PubMed  Google Scholar 

  • Gardano L, Pucci F, Christian L, Le Bihan T, Harrington L (2013) Telomeres, a busy platform for cell signaling. Front Oncol 3:146

    Article  PubMed  PubMed Central  Google Scholar 

  • Garnier D, Magnus N, Meehan B, Kislinger T, Rak J (2013) Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res 319:2747–2757

    Article  CAS  PubMed  Google Scholar 

  • Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D (2009) New insights into liver stem cells. Dig Liver Dis 41:455–462

    Article  CAS  PubMed  Google Scholar 

  • Gong P, Wang Y, Zhang J, Wang Z (2013a) Bone marrow mesenchymal stem cells in hepatocellular carcinoma. Front Biosc 18:811–819

    Article  CAS  Google Scholar 

  • Gong P, Wang Y, Wang Y, Jin S, Luo H, Zhang J, Bao H, Wang Z (2013b) Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation. Tumour Biol 34:2161–2168

    Article  CAS  PubMed  Google Scholar 

  • Grompe M (2005) Bone marrow-derived hepatocytes. Novartis Found Symp 265:20–27

    Article  PubMed  Google Scholar 

  • Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318

    Article  CAS  PubMed  Google Scholar 

  • Guest I, Ilic Z, Ma J, Grant D, Glinsky G, Sell S (2010) Direct and indirect contribution of bone marrow derived cells to cancer. Int J Cancer 126:2308–2318

    CAS  PubMed  PubMed Central  Google Scholar 

  • Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD (2014) Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol 20:2098–2106

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gupta DK, Singh N, Sahu DK (2014) TGF-b mediated crosstalk between malignant hepatocyte and tumor microenvironment in hepatocellular carcinoma. Cancer Growth Metastasis 7:1–8

    CAS  PubMed  PubMed Central  Google Scholar 

  • Guzman G, Cotler SJ, Lin AY, Maniotis AJ, Folberg R (2007) A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med 131:1776–1781

    PubMed  PubMed Central  Google Scholar 

  • Hagiwara S, Kudo M, Ueshima K, Chung H, Yamaguchi M, Takita M, Haji S, Kimura M et al (2011) The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon a-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol 46:212–221

    Article  CAS  PubMed  Google Scholar 

  • Han C, Sun B, Wang W, Cai W, Lou D, Sun Y, Zhao X (2011a) Overexpression of microtubule-associated protein-1 light chain 3 is associated with melanoma metastasis and vasculogenic mimicry. Tohoku J Exp Med 223:243–251

    Article  CAS  PubMed  Google Scholar 

  • Han S, Dziedzic N, Gadue P, Keller GM, Gouon-Evans V (2011b) An endothelial cell niche induces hepatic specification through dual repression of Wnt and Notch signaling. Stem Cells 29:217–228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hang HL, Xia Q (2014) Role of BMSCs in liver regeneration and metastasis after hepatectomy. World J Gastroenterol 20:126–132

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ (2010) Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70:10340–10350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y, Shalapour S, Seki E et al (2013) Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155:384–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R et al (2010) Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14:1605–1618

    Article  CAS  PubMed  Google Scholar 

  • Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, Seftor RE, Kinch MS et al (2001) Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 61:3250–3255

    CAS  PubMed  Google Scholar 

  • Hess AR, Margarayan NV, Seftor EA, Hendrix MJ (2007) Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn 236:3283–3296

    Article  CAS  PubMed  Google Scholar 

  • Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT (2006) Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 44:836–843

    Article  CAS  PubMed  Google Scholar 

  • Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z et al (2012) Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One 7, e37159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hou Y, Zou Q, Ge R, Shen F, Wang Y (2012) The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers. Cell Res 22:259–272

    Article  CAS  PubMed  Google Scholar 

  • Hugo HJ, Kokkinos MI, Blick T, Ackland ML, Thompson EW, Newgreen DF (2011) Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study. Cells Tissues Organs 193:23–40

    Article  PubMed  Google Scholar 

  • Idrissi ME, Hervieu V, Merle P, Mortreux F, Wattel E (2013) Cause-specific telomere factors deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res 32:64

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Imrich S, Hachmeister M, Gires O (2012) EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr 6:30–38

    Article  PubMed  PubMed Central  Google Scholar 

  • Ishikawa T, Banas A, Hagiwara K, Iwaguro H, Ochiya T (2010) Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells. Curr Stem Cell Res Ther 5:182–189

    Article  CAS  PubMed  Google Scholar 

  • Iwahashi S, Utsunomiya T, Shimada M, Saito Y, Morine Y, Imura S, Ikemoto T, Mori H et al (2013) High expression of cancer stem cell markers in cholangiocellular carcinoma. Surg Today 43:654–660

    Article  CAS  PubMed  Google Scholar 

  • Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM et al (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50:472–480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ji J, Wang XW (2012) Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 39:461–472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jia Y, Liu H, Zhuang Q, Xu S, Yang Z, Li J, Lou J, Zhang W (2012) Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol Rep 27:1865–1872

    CAS  PubMed  Google Scholar 

  • Jia SQ, Ren JJ, Dong PD, Meng XK (2013) Probing the hepatic progenitor cell in human hepatocellular carcinoma. Gastroenterol Res Pract. doi:10.1155/2013/145253

    PubMed  PubMed Central  Google Scholar 

  • Jing Y, Han Z, Liu Y, Sun K, Zhang S, Jiang G, Li R, Gao L, Zhao X, Wu D, Cai X et al (2012) Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One 7, e43372

    Article  CAS  Google Scholar 

  • Kamiya A, Gonzalez FJ, Nakauchi H (2006) Identification and differentiation of hepatic stem cells during liver development. Front Biosci 11:1302–1310

    Article  CAS  PubMed  Google Scholar 

  • Kamiya A, Inagaki Y (2015) Stem and progenitor cell systems in liver development and regeneration. Hepatol Res 45(1):29–37. doi:10.1111/hepr.12349

    Google Scholar 

  • Kamohara Y, Haraguchi N, Mimori K, Tanaka F, Inoue H, Mori M, Kanematsu T (2008) The search for cancer stem cells in hepatocellular carcinoma. Surgery 144:119–124

    Article  PubMed  Google Scholar 

  • Kappel D, Butter F, Benda C, Scheibe M, Draskovic I, Stevense M, Novo CL, Basquin C et al (2013) HOT1 is a mammalian direct telomere repeat-binding protein contributing to telomerase recruitment. EMBO J 32:1681–1701

    Article  CAS  Google Scholar 

  • Katoonizadeh A, Poustchi H, Malekzadeh R (2014) Hepatic progenitor cells in liver regeneration: current advances and clinical perspectives. Liver Int 34(10):1464–1472. doi:10.1111/liv.12573

    Article  PubMed  Google Scholar 

  • Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS et al (2011) Human hepatocellular carcinoms with “stemness”-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 54:1707–1717

    Article  CAS  PubMed  Google Scholar 

  • Kim SK, Nasu A, Komori J, Shimizu T, Matsumoto Y, Minaki Y, Kohno K, Shimizu K et al (2014) A model of liver carcinogenesis originating from hepatic progenitor cells with accumulation of genetic alterations. Int J Cancer 134:1067–1076

    Article  CAS  PubMed  Google Scholar 

  • Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ (2012) Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res 18:2726–2732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kitisin K, Pishvaian MJ, Johnson LB, Mishra L (2007) Liver stem cells and molecular signaling pathways in hepatocellular carcinoma. Gastrointest Cancer Res 1(suppl 2):S13–S21

    PubMed  PubMed Central  Google Scholar 

  • Klenova et al. (2002) Pub Med PMID 12191639

    Google Scholar 

  • Kohga K, Tasumi T, Takehara T, Tsunematsu H, Shimizu S, Yamamoto M, Sasakawa A et al (2010) Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma. J Hepatol 52:872–879

    Article  CAS  PubMed  Google Scholar 

  • Kuhlmann WD, Peschke P (2006) Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol 87:343–359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kupcova SH (2013) Proteomic techniques for characterization of mesenchymal stem cell secretome. Biochimie 95:2196–2211

    Article  CAS  Google Scholar 

  • Lai CY, Schwartz BE, Hsu MY (2012) CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res 72:5111–5118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lan X, Wu YZ, Wang Y, Wu FR, Zang CB, Tang C, Cao S, Li SL (2013) CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells. Int J Mol Med 31:315–324

    CAS  PubMed  Google Scholar 

  • Lau CK, Yang ZF, Fan ST (2011) Role of stem cells in normal liver and cancer. Anticancer Agents Med Chem 11:522–528

    Article  CAS  PubMed  Google Scholar 

  • Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY et al (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12:5369–5376

    Article  CAS  PubMed  Google Scholar 

  • Lee TK, Castilho A, Ma S, Ng IO (2009) Liver cancer stem cells: implications for a new therapeutic target. Liver Int 29:955–965

    Article  CAS  PubMed  Google Scholar 

  • Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J (2011) Microvesicles as mediators of intracellular communication in cancer-the emerging science of cellular ‘debris’. Semin Immunopathol 33:455–467

    Article  PubMed  Google Scholar 

  • Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS (2012a) Prognosis of hepatocellular carcinoma expression cytokeratin 19: comparison with other liver cancers. World J Gastroenterol 18:4751–4757

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee Y, El Andaloussi S, Wood MJ (2012b) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21:R125–R134

    Article  CAS  PubMed  Google Scholar 

  • Leelawat K, Tongtawee T, Narong S, Subwongcharoen S, Treepongkaruna SA (2011) Strong expression of CD133 is associated with increased cholangiocarcinoma. World J Gastroenterol 17:1192–1198

    Article  PubMed  PubMed Central  Google Scholar 

  • Lehwald N, Duhme C, Wildner M, Kuhn S, Fürst G, Forbes SJ, Jonas S, Robson SC et al (2014) HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection. Liver Int 34:89–101

    Article  CAS  PubMed  Google Scholar 

  • Li Z (2013) CD133: a stem cell biomarker and beyond. Exp Hematol Oncol 2:17

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li GC, Ye QH, Dong QZ, Ren N, Jia HL, Qin LX (2013) Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models. Oncol Rep 29:713–719

    CAS  PubMed  Google Scholar 

  • Lidprapamomgkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A, Svasti J (2012) Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 422:429–435

    Article  CAS  Google Scholar 

  • Lin WM, Karsten U, Goletz S, Cheng RC, Cao Y (2011) Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells. Int J Exp Pathol 92:97–105

    Article  PubMed  PubMed Central  Google Scholar 

  • Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, Wu J (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89:27–35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A, Svasti J (2012) Exploring stemness gene expression and vasculogenic mimicry capacity in well-and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 422:429–435

    Article  CAS  PubMed  Google Scholar 

  • Lissitzky JC, Parriaux D, Ristorcelli E, Vérine A, Lombardo D, Verrando P (2009) Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res 69:802–809

    Article  CAS  PubMed  Google Scholar 

  • Liu D, O’Connor MS, Qin J, Songyang Z (2004) Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279:51338–51342

    Article  CAS  PubMed  Google Scholar 

  • Liu LL, Fu D, Ma Y, Shen XZ (2011a) The power and the promise of liver cancer stem cell markers. Stem Cells Dev 20:2023–2030

    Article  CAS  PubMed  Google Scholar 

  • Liu WB, Xu GL, Jia WD, Li JS, Ma JL, Chen K, Wang ZH, Ge YS, Ren WH et al (2011b) Prognostic significance and mechanisms of patterened matrix vasculogenic mimicry in hepatocellular carcinoma. Med Oncol 28(suppl 1):S228–S238

    Article  PubMed  Google Scholar 

  • Liu W, Xu G, Ma J, Jia W, Li J, Chen K, Wang W, Hao C, Wang Y, Wang X (2011c) Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma. Tohoku J Exp Med 224:29–39

    Article  CAS  PubMed  Google Scholar 

  • Liu J, Huang J, Yao WY, Ben QW, Chen DF, He XY, Li L, Yuan YZ (2012) The origins of vascularization in tumors. Front Biosci 17:2559–2565

    Article  CAS  Google Scholar 

  • Liu S, Li N, Yu X, Xiao X, Cheng K, Hu J, Wang J, Zhang D, Cheng S, Liu S (2013a) Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Gastroenterology 144:1031–1041

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Ruan B, You N, Huang Q, Liu W, Dang Z, Xu W, Zhou T, Ji R, Cao Y, Li X et al (2013b) Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the b-catenin pathway in hepatic oval cells. PLoS One 8, e79409

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu AY, Cai Y, Mao Y, Lin Y, Zheng H, Wu T, Huang Y, Fang X, Lin S, Feng Q, Huang Z et al (2014) Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35:537–545

    Article  CAS  PubMed  Google Scholar 

  • Low KC, Tergaonkar V (2013) Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci 38:426–434

    Article  CAS  PubMed  Google Scholar 

  • Loukinov et al. (2002) Pub Med PMID 12011441

    Google Scholar 

  • Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542–2556

    Article  CAS  PubMed  Google Scholar 

  • Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY (2008) CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27:1749–1758

    Article  CAS  PubMed  Google Scholar 

  • Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N et al (2010) miR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7:694–707

    Article  CAS  PubMed  Google Scholar 

  • Ma JL, Han SX, Zhu Q, Zhao J, Zhang D, Wang L, Lv Y (2011) Role of twist in vasculogenic mimicry formation in hypoxic hepatocellular carcinoma cells in vitro. Biochem Biophys Res Commun 408:686–691

    Article  CAS  PubMed  Google Scholar 

  • Ma S (2013) Biology and clinical implications of CD133(+) liver cancer stem cells. Exp Cell Res 319:126–132

    Article  CAS  PubMed  Google Scholar 

  • Ma YC, Yang JY, Yan LN (2013) Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol 25:1007–1016

    Article  CAS  PubMed  Google Scholar 

  • Machida K, Feldman DE, Tsukamoto H (2015) TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis. Adv Exp Med Biol 815:131–144

    Article  PubMed  Google Scholar 

  • Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR et al (2012) Hepatic stem cells and transforming growth factor b in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 9:530–538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI, Osman KT, Kasimer D et al (2011) CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem 286:41046–41056

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, Trent JM, Meltzer PS et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mansuroglu T, Baumhoer D, Dudas J, Haller F, Cameron S, Lorf T, Füzesi L, Ramadori G (2009) Expression of stem cell factor receptor c-kit in human nontumoral and tumoral hepatic cells. Eur J Gastroenterol Hepatol 21:1206–1211

    Article  CAS  PubMed  Google Scholar 

  • Marquardt JU, Thorgeirsson SS (2010) Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis 30:26–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martin-Padura I, Marighetti P, Agliano A, Colombo F, Larzabal L, Redrado M, Bleau AM et al (2012) Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Lab Invest 92:952–966

    Article  CAS  PubMed  Google Scholar 

  • Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y et al (2009) Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 9:240

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • McAllister JC, Zhan Q, Weishaupt C, Hsu MY, Murphy GF (2010) The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol 37(Suppl1):19–25

    Article  PubMed  PubMed Central  Google Scholar 

  • Meacham C.E. and Morrison S.J. (2013). Tumour heterogeneity and cancer cell plasticity.Nature 501, 328–337

    Google Scholar 

  • Melero-Martin JM, Dudley AC (2011) Concise review: vascular stem cells and tumor angiogenesis. Stem Cells 29:163–168

    Article  CAS  PubMed  Google Scholar 

  • Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L et al (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49:318–329

    Article  PubMed  PubMed Central  Google Scholar 

  • Mizrak D, Brittan M, Allison MR (2008) CD133: molecule of the moment. J Pathol 214:3–9

    Article  CAS  PubMed  Google Scholar 

  • Mokarizadeh A, Rezvanfar MA, Dorostkar A, Abdollahi M (2013) Mesenchymal stem cell derived microvesicles: trophic shuttles for enhancement of sperm quality parameters. Reprod Toxicol 42C:78–84

    Article  CAS  Google Scholar 

  • Moriyama T, Ohuchida K, Mizumoto K, Cui L, Ikenaga N, Sato N, Tanaka M (2010) Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 116:3357–3368

    Article  CAS  PubMed  Google Scholar 

  • Muralidharan-Chari V, Clancy JW, Sedgwik A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muramatsu S, Tanaka S, Mogushi K, Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T et al (2013) Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course. Hepatology 58:218–228

    Article  CAS  PubMed  Google Scholar 

  • Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN (2011) Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol 90:66–73

    Article  CAS  PubMed  Google Scholar 

  • Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K et al (2014) Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci U S A 111:1090–1095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakayama M, Ogasawara S, Akiba J, Ueda K, Koura K, Todoroki K, Kinoshita H, Yano H (2014) Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells. J Gastroenterol Hepatol 29:1092–1101

    Article  CAS  PubMed  Google Scholar 

  • Navarro-Alvarez N, Soto-Gutierrez A, Kobayashi N (2010) Hepatic stem cells and liver development. Methods Mol Biol 640:181–236

    Article  CAS  PubMed  Google Scholar 

  • Nejak-Bowen KN, Monga SP (2011) Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 21:44–58

    Article  CAS  PubMed  Google Scholar 

  • Nishina H (2012) hDlk-1: a cell surface marker common to normal hepatic stem/progenitor cells and carcinomas. J Biochem 152:121–123

    Article  CAS  PubMed  Google Scholar 

  • Oh SH, Witek RP, Bae SH, Zheng D, Jung Y, Piscaglia AC, Petersen BE (2007) Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylfluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 132:1077–1087

    Article  CAS  PubMed  Google Scholar 

  • Ohnishi S, Maehara O, Nakagawa K, Kameya A, Otaki K, Fujita H, Higashi R, Takagi K et al (2013) Hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors. PLoS One 8, e66255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H et al (2013) Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 57:1469–1483

    Article  CAS  PubMed  Google Scholar 

  • Oishi N, Yamashita T, Kaneko S (2014) Molecular biology of liver cancer stem cells. Liver Cancer 3:71–84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oliva J, French BA, Qing X, French SW (2010) The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol 88:331–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334

    Article  CAS  PubMed  Google Scholar 

  • Pang RW, Poon RT (2012) Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma. Curr Cancer Drug Targets 12:1081–1094

    CAS  PubMed  Google Scholar 

  • Pap E (2011) The role of microvesicles in malignancies. Adv Exp Med Biol 714:183–199

    Article  CAS  PubMed  Google Scholar 

  • Papp V, Rokusz A, Dezsö K, Bugyik E, Szabo V, Pavai Z, Paku S, Nagy P (2014) Expansion of hepatic stem cell compartment boosts liver regeneration. Stem Cells Dev 23:56–65

    Article  CAS  PubMed  Google Scholar 

  • Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, Kong G, Kang KS, Nam JS (2011) Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. J Hepatol 54:122–131

    Article  CAS  PubMed  Google Scholar 

  • Parveen N, Aleem AK, Habeeb MA, Habibullah CM (2011) An update on hepatic stem cells: bench to bedside. Curr Pharm Biotechnol 12:226–230

    Article  CAS  PubMed  Google Scholar 

  • Paulis YW, Soetekouw PM, Verheul HM, Tjan-heijnen VC, Griffoen AW (2010) Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta 1806:18–28

    CAS  PubMed  Google Scholar 

  • Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS et al (1999) Bone marrow as a potential source of hepatic oval cells. Science 284:1168–1170

    Article  CAS  PubMed  Google Scholar 

  • Piao LS, Hur W, Kim TK, Hong SW, Kim SW, Choi JE, Sung PS, Song MJ, Lee BC et al (2012) CD133(+) liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett 315:129–137

    Article  CAS  PubMed  Google Scholar 

  • Ping YF, Bian XW (2011) Concise review: contribution of cancer stem cells to neovascularization. Stem Cells 29:888–894

    Article  CAS  PubMed  Google Scholar 

  • Qi W, Liang W, Jiang H, Miuyee WM (2013) The function of miRNA in hepatic cancer stem cell. Biomed Res Int 2013:358902

    Article  PubMed  PubMed Central  Google Scholar 

  • Quesenberry PJ, Aliotta JM (2010) Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 62:1141–1148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Quesenberry PJ, Dooner MS, Goldberg LR, Aliotta JM, Pereira M, Amaral A, Del Tatto MM et al (2012) A new stem cell biology: the continuum and microvesicles. Trans Am Clin Climatol Assoc 123:152–166

    PubMed  PubMed Central  Google Scholar 

  • Rappa G, Mercapide J, Anzanello F, Pope RM, Lorico A (2013) Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol Cancer 12:62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reagan MR, Kaplan DL (2011) Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 29:920–927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rodrigo-Torres D, Affo S, Coll M, Morales-Ibanez O, Millan C, Blaya D, Alvarez-Guaita A et al (2014) The biliary epithelium gives rise to liver progenitor cells. Hepatology 60(4):1367–1377. doi:10.1002/hep.27078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rodriguez RM, Fernandez AF, Fraga MF (2013) Role of sirtuins in stem cell differentiation. Genes Cancer 4:105–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosa-Garrido M, Ceballos L, Alonso-Lecue P, Abraira C, Delgado MD, Gandarillas A (2012) A cell cycle role for the epigenetic factor CTCF-L/BORIS. PLoS One 7, e39371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rountree CB, Ding W, Dang H, Vankirk C, Crooks GM (2011) Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp 56:3183

    PubMed  Google Scholar 

  • Rountree CB, Mishra L, Willenbring H (2012) Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology 55:298–306

    Article  PubMed  PubMed Central  Google Scholar 

  • Saeed H, Iqtedar M (2013) Stem cell function and maintenance – ends that matter: role of telomeres and telomerase. J Biosc 38:641–649

    Article  CAS  Google Scholar 

  • Sainz B, Heeschen C (2013) Standing out from the crowd: cancer stem cells in hepatocellular carcinoma. Cancer Cell 23:431–433, Cancer Lett 275:185–193

    Article  CAS  PubMed  Google Scholar 

  • Sangan CB, Tosh D (2010) Hepatic progenitor cells. Cell Tissue Res 342:131–137

    Article  PubMed  Google Scholar 

  • Sasaki A, Kamiyama T, Yokoo H, Nakanishi K, Kubota K, Haga H, Matsushita M, Ozaki M et al (2010) Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep 24:537–546

    Article  CAS  PubMed  Google Scholar 

  • Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, Hendrix MJ (2012) Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 181:1115–1125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sell S (1993) The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol 37:189–201

    CAS  PubMed  Google Scholar 

  • Sell S (2008) Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer. Tumour Biol 29:161–180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sell S, Leffert HL (2008) Liver cancer stem cells. J Clin Oncol 26:2800–2805

    Article  PubMed  PubMed Central  Google Scholar 

  • Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q, Ma L et al (2012) Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology 56:1004–1014

    Article  CAS  PubMed  Google Scholar 

  • Sharma AD, Cantz T, Manns MP, Ott M (2006) The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev 2:51–58

    Article  CAS  PubMed  Google Scholar 

  • Shen Y, Cao D (2012) Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. Front Biosc (Elide Ed) 4:1157–1169

    Article  Google Scholar 

  • Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, Li X, He Z, Gong W, Qin R (2010) CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther 10:1182–1190

    Article  CAS  PubMed  Google Scholar 

  • Shih YT, Wang MC, Zhou J, Peng HH, Lee DY, Chiu JJ (2014) Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21. Gut 64(7):1132–1147. doi:10.1136/gutjnl-2013-306302

    Article  PubMed  CAS  Google Scholar 

  • Shin D, Monga SP (2013) Cellular and molecular basis of liver development. Comp Physiol 3:799–815

    Google Scholar 

  • Shupe T, Petersen BE (2005) Evidence regarding a stem cell origin of hepatocellular carcinoma. Stem Cell Rev 1:261–264

    Article  CAS  PubMed  Google Scholar 

  • Song W, Li H, Tao K, Li R, Song Z, Zhao Q, Zhang F, Dou K (2008) Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract 62:1212–1218

    Article  CAS  PubMed  Google Scholar 

  • Song YJ, Zhang SS, Guo XL, Sun K, Han ZP, Li R, Zhao QD, Deng WJ, Xie XQ et al (2013) Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett 339:70–81

    Article  CAS  PubMed  Google Scholar 

  • Stock P, Brückner S, Winkler S, Dollinger MM, Christ B (2014) Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury. Int J Mol Sci 15:7004–7028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strain AJ, Crosby HA, Nijar S, Kelly DA, Hubscher SG (2003) Human liver-derived stem cells. Semin Liver Dis 23:373–384

    Article  CAS  PubMed  Google Scholar 

  • Su F, Li B, Wang J, Xu X, Ren R, Li L, Gao F, Liu X (2009) Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix ld2 (inhibitor of DANN binding 2). Graefes Arch Clin Exp Ophthalmol 247:411–419

    Article  CAS  PubMed  Google Scholar 

  • Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351:820–824

    Article  CAS  PubMed  Google Scholar 

  • Suetsugu A, Osawa Y, Nagaki M, Moriwaki H, Saji S, Bouvet M, Hoffman RM (2010) Simultaneous color-coded imaging to distinguish cancer “stem-like” and non-stem cells in the same tumor. J Cell Biochem 111:1035–1041

    Article  CAS  PubMed  Google Scholar 

  • Sukowati CH, Tiribelli C (2013) The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy. Expert Rev Gastroenterol Hepatol 7:749–757

    Article  CAS  PubMed  Google Scholar 

  • Sun B, Zhang S, Zhang D, Du J, Guo H, Zhao X, Zhang W, Hao X (2006) Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 16:693–698

    CAS  PubMed  Google Scholar 

  • Sun B, Zhang D, Zhang S, Zhang W, Guo H, Zhao X (2007) Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related expression in melanoma. Cancer Lett 249:188–197

    Article  CAS  PubMed  Google Scholar 

  • Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N, Wang XH, Du J, Liu YX, Sun BC (2010) Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology 51:545–556

    Article  CAS  PubMed  Google Scholar 

  • Sun T, Sun BC, Zhao XL, Zhao N, Dong XY, Che N, Yao Z, Ma YM, Gu Q, Zong WK et al (2011) Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology 54:1690–1706

    Article  CAS  PubMed  Google Scholar 

  • Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC, Zhou X, Ding YT (2012) Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma. World J Gastroenterol 18:4925–4933

    Article  PubMed  PubMed Central  Google Scholar 

  • Sun C, Sun L, Jiang K, Gao DM, Kang XN, Wang C, Zhang S, Huang S, Qin X, Li Y et al (2013a) NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. Int J Biochem Cell Biol 45:1099–1108

    Article  CAS  PubMed  Google Scholar 

  • Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q, Dong X, Yao Z, Li R, Li J, Chi J, Sun R (2013b) Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med 17:1038–1047

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang KH, Ma S, Lee TK, Chan YP, Kwan PS, Tong CM, Ng IO, Man K, To KF et al (2012) CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology 55:807–820

    Article  CAS  PubMed  Google Scholar 

  • Tang J, Tao ZH, Wen D, Wan JL, Liu DL, Zhang S, Cui JF, Sun HC, Wang L, Zhou J et al (2014) miR-612 suppresses the stemness of liver cancer via Wnt/b-catenin signaling. Biochem Biophys Res Commun 447:210–215

    Article  CAS  PubMed  Google Scholar 

  • Terris B, Cavard C, Perret C (2010) EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. J Hepatol 52:280–281

    Article  CAS  PubMed  Google Scholar 

  • Teufel A, Galle PR (2010) Collecting evidence for a stem cell hypothesis in HCC. Gut 59:870–871

    Article  CAS  PubMed  Google Scholar 

  • Tiffen JC, Bailey CG, Marshall AD, Metierre C, Feng Y, Wang Q, Watson SL, Holst J et al (2013) The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells. Int J Cancer 133:1603–1613

    Article  CAS  PubMed  Google Scholar 

  • Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, Pintea B, Foris V et al (2010) Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis 19:61–67

    PubMed  Google Scholar 

  • Tong CM, Ma S, Guan XY (2011) Biology of hepatic cancer stem cells. J Gastroenterol Hepatol 26:1229–1237

    Article  CAS  PubMed  Google Scholar 

  • Toshima T, Yoshizumi T, Uchiyama H, Ikegami T, Soejima Y, Ikeda T, Kawanaka H et al (2013) Effect of Cd133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation: a case report. Fukuoka Igaku Zasshi 104:383–388

    PubMed  Google Scholar 

  • Tsai ST, Tsou CC, Mao WY, Chang WC, Han HY, Hsu WL, Li CL, Shen CN et al (2012) Label-free quantitative proteomics of CD133-positive liver cancer stem cells. Proteome Sci 10:69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsuchiya A, Kamimura H, Tamura Y, Takamura M, Yamagiwa S, Suda T, Nomoto M et al (2011) Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM. Cancer Lett 309:95–103

    Article  CAS  PubMed  Google Scholar 

  • Valyi-Nagy K, Kormos B, Ali M, Shukla D, Valyi-Nagy T (2012) Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures. Mol Vis 18:588–592

    CAS  PubMed  PubMed Central  Google Scholar 

  • Vartanian A, Gatsina G, Grigorieva I, Solomko E, Dombrovsky V, Baryshnikov A, Stepanova E (2013) The involvement of Notch signaling in melanoma vasculogenic mimicry. Clin Exp Med 13:201–209

    Article  CAS  PubMed  Google Scholar 

  • Vessey CJ, de la Hall PM (2001) Hepatic stem cells: a review. Pathology 33:130–141

    Article  CAS  PubMed  Google Scholar 

  • Vestentoft PS (2013) Development and molecular composition of the hepatic progenitor cell niche. Dan Med J 60:B4640

    PubMed  Google Scholar 

  • Wang B, Jacob ST (2011) Role of cancer stem cells in hepatocarcino-genesis. Genome Med 3:11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang H, Chen L (2013) Tumor microenvironment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol 28(suppl 1):43–48

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Guo ZY, Zhang R, Xin B, Chen R, Zhao J, Wang T, Wen WH, Jia LT, Yao LB et al (2013) Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis 34:773–781

    CAS  Google Scholar 

  • Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, Yang N, Zhou WP, Li WL, Li W, Sun SH (2014) Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60:1278–1290

    Article  CAS  PubMed  Google Scholar 

  • Wells RG (2014) The portal fibroblast – Not just a poor man’s stellate cell. Gastroenterology 147(1):41–47. doi:10.1053/j.gastro.2014.05.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC et al (2011) Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 140:1063–1070

    Article  CAS  PubMed  Google Scholar 

  • Wu XZ, Chen D (2006) Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21:1093–1098

    Article  CAS  PubMed  Google Scholar 

  • Wu Y, Wu PY (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18:1127–1134

    Article  CAS  PubMed  Google Scholar 

  • Wu KJ, Yang MH (2011) Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosci Rep 31:449–455

    Article  PubMed  CAS  Google Scholar 

  • Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, Huang L, Han T, Yang W, Wang C et al (2012) Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology 56:2255–2267

    Article  CAS  PubMed  Google Scholar 

  • Xin H, Liu D, Songyang Z (2008) The telosome/shelterin complex and its functions. Genome Biol 9:232

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xiong W, Sun LP, Chen XM, Li HY, Huang SA, Jie SH (2013) Comparison of microRNA expression profiles in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC. J Huazhong Univ Sci Technolog Med Sci 33:346–352

    Article  CAS  PubMed  Google Scholar 

  • Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu ZL, Li JY, Xie Y, Gu J, Wang Y et al (2010a) The properties of tumor-initiating cells from a hepatocellular carcinoma patient’s primary and recurrent tumor. Carcinogenesis 31:167–174

    Article  CAS  PubMed  Google Scholar 

  • Xu X, Xing B, Hu M, Xu Z, Xie Y, Dai G, Gu J, Wang Y, Zhang Z (2010b) Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy. Cytotherapy 12:190–200

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Xie Y, Wang X, Chen X, Liu Q, Ying M, Zheng Q (2013) Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs. Oncol Rep 30:2056–2062

    CAS  PubMed  Google Scholar 

  • Xue X, Zhang Y, Zhi Q, Tu M, Xu Y, Sun J, Wei J, Lu Z, Miao Y, Gao W (2014) MiR200-upregulated vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Commun Signal 12:62

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX et al (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012–1024

    Article  CAS  PubMed  Google Scholar 

  • Yamashita T, Wang XW (2013) Cancer stem cells in the development of liver cancer. J Clin Invest 123:1911–1918

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T et al (2013) Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology 57:1484–1497

    Article  CAS  PubMed  Google Scholar 

  • Yamashita T, Kaneko S (2014) Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells. J Gastroenterol 49:1105–1110

    Article  CAS  PubMed  Google Scholar 

  • Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J (2013) Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Mol Carcinog 53(12):960–969. doi:10.1002/mc.22064

    PubMed  Google Scholar 

  • Yanai H, Nakamura K, Hijoka S, Kamei A, Ikari T, Ishikawa Y, Shinozaki E, Mizunuma N et al (2010) Dlk-1, a cell surface antigen on fetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J Biochem 148:85–92

    Article  CAS  PubMed  Google Scholar 

  • Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L et al (2008) Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 68:4287–4295

    Article  CAS  PubMed  Google Scholar 

  • Yang ZF, Poon RT (2008) Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) 291:721–734

    Article  CAS  Google Scholar 

  • Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B et al (2010) High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59:953–962

    Article  CAS  PubMed  Google Scholar 

  • Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL et al (2012) OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma. J Hepatol 57:613–620

    Article  CAS  PubMed  Google Scholar 

  • Yao Z, Mishra L (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8:1691–1698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yao XH, Ping YF, Bian XW (2011) Contribution of cancer stem cells to tumor vasculogenic mimicry. Protein Cell 2:266–272

    Article  PubMed  PubMed Central  Google Scholar 

  • Ye J, Wu Y, Gilson E (2010) Dynamics of telomeric chromatin at the crossroads of aging and cancer. Essays Biochem 48:147–164

    Article  CAS  PubMed  Google Scholar 

  • Yeh CT, Kuo CJ, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC (2009) CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer 9:324

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yi SY, Nan KJ (2008) Tumor-initiating stem cells in liver cancer. Cancer Biol Ther 7:325–330

    Article  CAS  PubMed  Google Scholar 

  • Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, Yang S et al (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120:1444–1450

    Article  CAS  PubMed  Google Scholar 

  • Yin C, Evason KJ, Asahina K, Stainier DY (2013) Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 123:1902–1910

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF et al (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 368:2266–2276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoon SK (2012) The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma. Gut Liver 6:29–40

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoshikawa S, Zen Y, Fukii T, Sato Y, Ohta T, Aoyagi Y, Nakanuma Y (2009) Characterization of CD133+ parenchymal cells in the liver: histology and culture. World J Gastroenterol 15:4896–4906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • You H, Ding W, Rountree CB (2010) Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 51:1635–1644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu DC, Chen J, Sun XT, Zhuang LY, Jiang CP, Ding YT (2010a) Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer 10:435

    Article  PubMed  PubMed Central  Google Scholar 

  • Yu DC, Chen J, Ding YT (2010b) Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the ‘niche’ of endothelial progenitor cells. Int J Mol Sci 11:2901–2909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu XH, Xu LB, Liu C, Zhang R, Wang J (2011) Clinicopathologic characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. Dig Dis Sci 56:252–259

    Article  PubMed  Google Scholar 

  • Yu G, Jing Y, Kou X, Ye F, Gao L, Fan Q, Yang Y, Zhao Q, Li R, Wu M, Wei L (2013a) Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. PLoS One 8, e73312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu B, He ZY, You P, Han QW, Xiang D, Chen F, Wang MJ, Liu CC, Lin XW, Borjigin U et al (2013b) Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell 13:328–340

    Article  CAS  PubMed  Google Scholar 

  • Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmeddov NB, Farber DB (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4, e4722

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yun WJ, Shin E, Lee K, Jung HY, Kim SH, Park YN, Yu E, Jang JJ (2013) Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma. Pathol Res Pract 209:568–573

    Article  CAS  PubMed  Google Scholar 

  • Zenali MJ, Tan D, Li W, Dhingra S, Brown RE (2010) Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to comparisons to conventional hepatocellular carcinoma. Ann Clin Lab Sci 40:126–134

    PubMed  Google Scholar 

  • Zhai JM, Yin XY, Hou X, Hao XY, Cai P, Liang LJ, Zhang LJ (2013) Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma. Dig Dis Sci 58:1934–1947

    Article  CAS  PubMed  Google Scholar 

  • Zhang A, London R, Schulz FM, Giguère-Simmonds PW, Delriviere L, Chandraratana H et al (2010) Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinoma. Stem Cells Dev 19:1277–1284

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S (2012) microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol 40:747–756

    CAS  PubMed  Google Scholar 

  • Zhang C, Xu Y, Zhao J, Fan L, Jiang G, Li R, Ling Y, Wu M, Wie L (2011) Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Ann Surg Oncol 18:2373–2380

    Article  PubMed  Google Scholar 

  • Zhao XL, Du J, Zhang SW, Liu XY, Wang X, Sun BC (2006) A study on vasculogenic mimicry in hepatocellular carcinoma (in Chinese). Zhonghua Gan Zang Bing Za Zhi 14:41–44

    PubMed  Google Scholar 

  • Zhao J, Huang JS, Yang AJ, Wang CY, Liu W, Li M (2007) Three-dimension cell culture and histology of vasculogenic mimicry in hepatocellular carcinoma (in Chinese). Ai Zheng 26:123–126

    CAS  PubMed  Google Scholar 

  • Zhao N, Sun BC, Sun T, Ma YM, Zhao XL, Liu ZY, Dong XY, Che N, Mo J, Gu Q (2012) Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2. Med Oncol 29:3599–3607

    Article  CAS  PubMed  Google Scholar 

  • Zheng YW, Taniguchi H (2003) Diversity of hepatic stem cells in the fetal and adult liver. Semin Liver Dis 23:337–348

    Article  CAS  PubMed  Google Scholar 

  • Zheng T, Wang J, Jiang H, Liu L (2011) Hippo signaling in oval cells and hepatocercinogenesis. Cancer Lett 302:91–99

    Article  CAS  PubMed  Google Scholar 

  • Zheng YW, Nie YZ, Taniguchi H (2013) Cellular reprogramming and hepatocellular carcinoma development. World J Gastroenterol 19:8850–8860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou L, Yang ZX, Song WJ, Li QJ, Yang F, Wang DS, Zhang N, Dou KF (2013) MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int J Oncol 43:661–669

    CAS  PubMed  Google Scholar 

  • Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J (2010) Cancer stem/progenitor cells are highly enriched in CD133+ CD44+ population in hepatocellular carcinoma. Int J Cancer 126:2067–2078

    Article  CAS  PubMed  Google Scholar 

  • Zhu H, Shao Q, Sun X, Deng Z, Yuan X, Yu D, Zhou X, Ding Y (2012a) The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth. Oncol Rep 28:1217–1224

    CAS  PubMed  Google Scholar 

  • Zhu H, Shao Q, Sun X, Deng Z, Yuan X, Zhou X, Ding Y (2012b) Bone marrow cells: important role on neovascularization of hepatocellular carcinoma. J Gastroenterol Hepatol 27:1241–1251

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann A (2005) The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur J Cancer 41:1503–1514

    Article  PubMed  Google Scholar 

  • Zou GM (2008) Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 217:598–604

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Bern, Bern, Switzerland

    Arthur Zimmermann

Authors
  1. Arthur Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur Zimmermann .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this entry

Cite this entry

Zimmermann, A. (2017). Liver Cancer: Stem and Progenitor Cells. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26956-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26954-2

  • Online ISBN: 978-3-319-26956-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation